Prizes and parasites: incentive models for addressing Chagas disease.
Recent advances in immunology have provided a foundation of knowledge to understand many of the intricacies involved in manipulating the human response to fight parasitic infections, and a great deal has been learned from malaria vaccine efforts regarding strategies for developing parasite vaccines. There has been some encouraging progress in the development of a Chagas vaccine in animal models. A prize fund for Chagas could be instrumental in ensuring that these efforts are translated into products that benefit patients.
Crager
Sara E
SE
Yale University, USA.
Price
Matt
M
D000276:Adjuvants, Immunologic / Q000191:economics; D001363:Awards and Prizes; D035843:Biomedical Research / Q000191:economics*; D014355:Chagas Disease / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D009965:Orphan Drug Production / Q000191:economics*; D016052:Protozoan Vaccines / Q000191:economics; D014344:Trypanocidal Agents / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D016052:Protozoan Vaccines; D014344:Trypanocidal Agents